Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
ClinicalTrials.gov
International Multicenter Prospective, Non-competitive, Observational Study to Validate and Optimize Prediction Models of 90-day and 1-year Allograft Failure After Liver Transplantation
OBSERVATIONAL
Inicio: 1 de abr de 2022
ID: NCT05289609
Reclutando
Fase 3
ClinicalTrials.gov
Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
INTERVENTIONAL
Inicio: 2 de jul de 2025
ID: NCT07177352
Completado
ClinicalTrials.gov
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT01582763
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00720798
Completado
Fase 3
ClinicalTrials.gov
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00332917
Desconocido
ClinicalTrials.gov
Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's Disease
OBSERVATIONAL
Inicio: 6 de ene de 2020
ID: NCT05308485
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
INTERVENTIONAL
Inicio: 27 de dic de 2023
ID: NCT06141486
Reclutando
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, PARALLEL GROUP STUDY TO INVESTIGATE INTERMITTENT PREVENTION OF MENSTRUAL MIGRAINE WITH RIMEGEPANT COMPARED WITH PLACEBO IN WOMEN PARTICIPANTS 18 TO 45 YEARS OF AGE
INTERVENTIONAL
Inicio: 11 de mar de 2025
ID: NCT06641466
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib
INTERVENTIONAL
Inicio: 13 de dic de 2021
ID: NCT05156281
Activo, no recluta
Fase 3
ClinicalTrials.gov
A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension
INTERVENTIONAL
Inicio: 5 de oct de 2021
ID: NCT04926818
Reclutando
ClinicalTrials.gov
Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition and Nutritional Status of Iron and DHA in Infant Red Blood Cells.. Study in a Vulnerable Population.
INTERVENTIONAL
Inicio: 1 de jun de 2024
ID: NCT06319079
Desconocido
ClinicalTrials.gov
Incidence of de Novo Hepatocellular Carcinoma After Direct-acting Antiviral Agents for HCV: a Multicenter Prospective Cohort Study From Latin America.
OBSERVATIONAL
Inicio: 1 de may de 2016
ID: NCT03775798
Reclutando
ClinicalTrials.gov
Effectiveness of Post Muscle Inhibition Specific Joint Mobilization on Range of Motion and Pain in Patients With Mechanical Neck Pain
INTERVENTIONAL
Inicio: 30 de ago de 2021
ID: NCT05447338
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-related Symptoms Are Inadequately Controlled by Somatostatin Analogues.
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00690430
Completado
Fase 3
ClinicalTrials.gov
A Placebo-controlled, Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants
INTERVENTIONAL
Inicio: 5 de ago de 2003
ID: NCT00140673
Reclutando
ClinicalTrials.gov
NEVA ONE One-Pass Reperfusion With the NeVa Stent-Retriever EMEA Registry
INTERVENTIONAL
Inicio: 1 de jul de 2020
ID: NCT04562194
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Double-blind, Randomized Study of RVT-101 Versus Placebo When Added to Existing Stable Donepezil Treatment in Subjects With Mild to Moderate Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de oct de 2015
ID: NCT02585934
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE Plus)
INTERVENTIONAL
Inicio: 18 de may de 2021
ID: NCT04777409
Completado
ClinicalTrials.gov
Variaciones En El Elctrocardiograma Como Prediccion Del Desarrollo De Fibrilacion AURIC
OBSERVATIONAL
Inicio: 1 de jul de 2011
ID: NCT01405209
Completado
Fase 3
ClinicalTrials.gov
International, Randomized, Multicenter, Phase IIIb Study in Patients With Relapsing-Remitting Multiple Sclerosis Comparing Over a Treatment Period of at Least 104 Weeks: 1. Double-Blinded Safety, Tolerability, and Efficacy of Betaseron/ Betaferon 250 µg (8 MIU) and Betaseron/-Betaferon 500 µg (16 MIU), Both Given Subcutaneously Every Other Day, and 2. Rater-Blinded Safety, Tolerability, and Efficacy of Betaseron/-Betaferon s.c. Every Other Day With Copaxone 20 mg s.c. Once Daily.
INTERVENTIONAL
Inicio: 1 de nov de 2003
ID: NCT00099502
Anterior
1
...
24
25
26
...
434
Siguiente
Filtros